Wolverine Asset Management LLC Aerie Pharmaceuticals Inc Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.37 - $15.23 $75,427 - $180,338	11,841 New	11,841 $179,000
Q1 2022 May 04, 2022	SELL	$5.64 - $9.8 $3,530 - $6,134	-626 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$7.02 - $13.33 $4,394 - $8,344	626 New	626 $4,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $87,487 - $120,943	-8,364 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $30,000 - $40,325	-2,500 Reduced 23.01%	8,364 $123,000
Q1 2020 May 13, 2020	BUY	$11.84 - $25.52 $128,629 - $277,249	10,864 New	10,864 $146,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.